Open Access

[Retracted] Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin

  • Authors:
    • Yang Qu
    • Peng Xia
    • Shanyong Zhang
    • Su Pan
    • Jianwu Zhao
  • View Affiliations

  • Published online on: October 29, 2021     https://doi.org/10.3892/or.2021.8213
  • Article Number: 2
  • Copyright : © Qu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Related Articles

Journal Cover

January-2022
Volume 47 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Qu Y, Xia P, Zhang S, Pan S and Zhao J: [Retracted] Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin. Oncol Rep 47: 2, 2022
APA
Qu, Y., Xia, P., Zhang, S., Pan, S., & Zhao, J. (2022). [Retracted] Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin. Oncology Reports, 47, 2. https://doi.org/10.3892/or.2021.8213
MLA
Qu, Y., Xia, P., Zhang, S., Pan, S., Zhao, J."[Retracted] Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin". Oncology Reports 47.1 (2022): 2.
Chicago
Qu, Y., Xia, P., Zhang, S., Pan, S., Zhao, J."[Retracted] Silencing XIAP suppresses osteosarcoma cell growth, and enhances the sensitivity of osteosarcoma cells to doxorubicin and cisplatin". Oncology Reports 47, no. 1 (2022): 2. https://doi.org/10.3892/or.2021.8213